1 / 87

Management of Local Anaesthesia in Endodontics

Management of Local Anaesthesia in Endodontics. Halton -Peel Dental Association Andrew Moncarz BSc , DDS, Dip. An, MSc , FRCD(C) March 22, 2007. Objectives. Review of: Reported rates of profound anaesthesia Anatomical variations Maximum doses of local anaesthetics

Download Presentation

Management of Local Anaesthesia in Endodontics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management of Local Anaesthesia in Endodontics Halton-Peel Dental Association Andrew Moncarz BSc, DDS, Dip. An, MSc, FRCD(C) March 22, 2007

  2. Objectives • Review of: • Reported rates of profound anaesthesia • Anatomical variations • Maximum doses of local anaesthetics • Pulpal inflammation as a complicating factor • Adjunctive strategies for profound mandibular LA

  3. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  4. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  5. What about experienced operators?

  6. Effectiveness of Conventional IANB as measured by EPT

  7. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  8. Always use a long 25 gauge needle (the red one) • 2 reasons: • 1. Less deflection • 2. Less false negative aspiration

  9. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  10. Ultrasound Guidance • Hannan et al. 1999: • Repeated-measures design • 40 subjects injected twice at separate appointments—once with landmarks, once with ultrasound guidance • EPT after profound lip numbness reported • Anaesthetic success 38%-92%, no difference between the techniques • Conclusion: accuracy of needle placement is not the primary reason for failure of IANB

  11. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  12. Nerve to mylohyoid

  13. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  14. Berns et al. 1962: injected radiopaque material into pterygomandibular space • Spread is unpredictable • Suggestion: inject more LA

  15. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  16. Decrease in the pH locally • Can influence the amount of LA available in the lipophilic form to diffuse across the nerve membrane • Result is less drug interference of sodium channels • Less likely to influence mandibular block anaesthesia

  17. Reported Reasons for Mandibular Anaesthesia Failure • Operator Inexperience • Armamentarium: Deflection of the needle tip • Patient factors: • Variations in anatomy • Accessory innervation • Unpredictable spread of LA • Local infection • Pulpal inflammation • Psychological issues

  18. Pulpal Inflammation • Causes activation and sensitization of peripheral nociceptors • Causes sprouting of nerve terminals in the pulp • Causes expression of different sodium channels: TTX-resistant class of sodium channels are 4 times as resistant to blockade by lidocaine and their expression is doubled in the presence of PGE2

  19. Effectiveness of Conventional IANB: Irreversible Pulpitis 100% lip anaesthesia

  20. Adjunctive Strategies • Additional Anaesthetic • PDL Injection • Intraosseous Injection • Intrapulpal Injection • Different anaesthetic • Retest using the CC

  21. Adjunctive Strategies • Additional Anaesthetic • Higher injection • Gow Gates • Akinosi • Nerve to mylohyoid • PDL Injection • Intraosseous Injection • Intrapulpal Injection • Different anaesthetic

  22. Maximum Doses LA • % means g/dL • Example: • 1% = 1 g/dL • 1% = 10g/L • 1% = 10 mg/mL • Therefore: • 2% = 20 mg/mL

  23. Maximum Doses LA • A cartridge contains 1.8 mL • Therefore a cartridge of 2% local anaesthetic contains 20 mg/mL X 1.8 mL = 36 mg of local anaesthetic

  24. Maximum Doses LA • How much LA can you give? • 193 lb 33 yo male • Lidocaine 2% 1:100K • Articaine 4% 1:200K • 2.2 lbs = 1 kg • 193 lbs = 88 kg

  25. Lidocaine 2% Max dose = 7 mg/kg 7mg/kg X 88=616 mg 36 mg/1.8 mL 616mg/36mg/cart.= 17 cartridges ** Articaine 4% Max dose 7 mg/kg 7 X 88 = 616 mg 72 mg/1.8mL 616 mg/72 mg/cart. = 9 cartridges Maximum Doses LA

  26. Maximum Doses Epi • % = 1/100 = g/dL • Therefore: • 1/100 = 1% = 1g/dL = 10 mg/mL • 1/1000 = 0.1% = 0.1 g/dL = 1 mg/mL • 1/10000 = 0.01% = 0.01 g/dL = 0.1 mg/mL • 1/100000 = 0.001% = 0.001 g/dL = 0.01mg/mL • A cartridge contains 1.8 mL • Therefore a cartridge of 1:100 000 epi contains 0.01 mg/mL X 1.8 mL = 0.018 mg (or about 0.02 mg)

  27. Maximum Doses Epi • Cardiovascular patient 0.04 mg • Healthy patient 0.2 mg

  28. Lidocaine 2% Max dose = 7 mg/kg 7mg/kg X 88=616 mg 36 mg/1.8 mL 616mg/36mg/cart.= 17 cartridges ** 10-11 cartridges (epi) Articaine 4% Max dose 7 mg/kg 7 X 88 = 616 mg 72 mg/1.8mL 616 mg/72 mg/cart. = 9 cartridges Maximum Doses LA

  29. Pregnant Patients • Which Local Anaesthetic to use? • Articaine 4% 1:200 000 epi • Lidocaine 2% 1:100 000 epi • Mepivacaine 2% 1:20 000 levo • Mepivacaine 3% plain

  30. FDA categories (based on risk of fetal injury) • A: controlled studies in humans—no risk to fetus demonstrated • B: animal studies show no risk, no human studies; or animal studies have shown a risk but human studies have shown no risk • C: animal studies show risk, no human studies; or no animal or human studies

  31. Pregnant Patients • Which Local Anaesthetic to use? • Articaine 4% 1:200 000 FDA category C • Lidocaine 2% 1:100 000 FDA category B • Mepivacaine 2% 1:20 000 FDA category C • Mepivacaine 3% plain FDA category C

  32. Advantages of Injecting “Higher” • Failure to achieve profound local anaesthesia attributed to being “too low” and “too far forward” • Injecting superiorly and more distally may block accessory innervation • 3 nodes of Ranvier may not be true

  33. Gow-Gates Technique • Landmarks: • Corner of the mouth (contralateral side) • Tragus of the ear • Disto palatal cusp of the maxillary second molar • AIMING FOR THE NECK OF THE CONDYLE

  34. Efficacy of the Gow-Gates Technique

  35. Akinosi Technique • Closed-mouth technique • Does not rely on a hard-tissue landmark • Parallel to occlusal plane, height of the mucogingival junction • Advanced until hub is level with distal surface of maxillary second molar • Delayed onset of anaesthesia

  36. Akinosi Technique • Martinez Gonzalez et al. 2003 • Pain to puncture less with Akinosi • Onset slower • 17.8% failure vs. 10.7% IAB/LB • BUT-incomplete LB considered failure • Cruz et al. 1994 • Gow Gates more effective, but Akinosi most acceptable to patients

  37. Nerve to Mylohyoid • Deposit ¼ cartridge of LA on lingual surface of tooth in alveolar mucosa • Goal is to bathe the nerve as branches of it enter the lingual surface of the mandible

  38. Adjunctive Strategies • Additional Anaesthetic • PDL Injection • Intraosseous Injection • Intrapulpal Injection • Different anaesthetic

  39. PDL Injection • Technique: • needle inserted into the gingival sulcus at a 30 degree angle towards the tooth • bevel placed towards bone • advanced until resistance felt • anaesthetic injected with continuous force for about 15 seconds. • approx. 0.2 mL of solution • 25 vs. 30 gauge needle

  40. PDL Injection • Conventional vs. specific PDL syringes:  • Malamed (1982): • similar rates of success • D’Souza et al (1987): • no sig. difference in anaesthesia achieved. • using the pressure syringe resulted in more spread of anaesthetic to adjacent teeth  

  41. PDL Injection: Primary Technique • Melamed 1982: 86% overall • Faulkner 1983: 81% overall • White 1988: variable, short duration esp. md. molars • Walton 1990: “In reviewing the clinical and experimental literature…the periodontal ligament injection does not meet all of the necessary requirements for a primary technique.”

More Related